eTG complete home page
About Therapeutic Guidelines
Getting to know your drugs
Analgesic
Antibiotic
Cardiovascular
Dermatology
Emergency Medicine
Endocrinology
Gastrointestinal
Fatigue: diagnostic approach in primary care
Neurology
Oral and Dental
Palliative Care
Psychotropic
Contributors
Preface
Getting to know your psychotropic drugs
Introduction
Antidepressants
General information
Selective serotonin reuptake inhibitors
Mirtazapine and mianserin
Moclobemide
Reboxetine
Serotonin and noradrenaline reuptake inhibitors
Tricyclic antidepressants
Phenelzine and tranylcypromine
Pharmacokinetic properties and relative frequency of common adverse effects of SSRIs and other newer antidepressants at usual therapeutic doses (Table 8.2)
Pharmacokinetic properties and relative frequency of common adverse effects of TCAs, phenelzine and tranylcypromine at usual therapeutic doses (Table 8.4)
Drugs used in bipolar disorder
Anxiolytics and hypnotics
Antipsychotic drugs
Anticholinergic antiparkinsonian drugs
Drugs used to treat attention deficit hyperactivity disorder
Drugs used in substance use disorders
Drugs used in dementia
Other drugs used in psychiatric illnesses
Pertinent practical points
Anxiety and associated disorders
Sleep disorders
Mood disorders
Schizophrenia and related psychoses
Behavioural emergencies
Delirium
Dementia
Substance use disorders
Personality disorders
Eating disorders
Disorders usually first diagnosed in childhood and adolescence
Patient resources and support organisations (Appendix 8.1)
Sources of information and assistance (Appendix 8.2)
Clinical Institute Withdrawal of Alcohol Scale, revised (CIWA-Ar) (Appendix 8.3)
List of tables and boxes
Key references
Respiratory
Rheumatology
Ulcer and wound management
Developmental Disability
Drug use in pregnancy and breastfeeding